Incidence of TEL/AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse

Blood

Volumn 90, Issue 12, 1997, Pages 4933-4937

  Harbott, J ^b   Viehmann, S ^b   Borkhardt, A ^b   Henze, G ^b   Lampert, F ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER RECURRENCE; CANCER REGRESSION; CHILD; CHILDHOOD LEUKEMIA; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION 12; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE FUSION; HUMAN; HUMAN CELL; INFANT; MALE; PRIORITY JOURNAL;

EID: 0031440492     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.12.4933     Document Type: Article

References (32)

1. Romana SP, Le Coniat M, Berger R: t(12;21): A new recurrent translocation in acute lymphoblastic leukemia. Genes Chromosomes Cancer 9:186, 1994
2. McLean TW, Ringold S, Neuberg D, Stegmaier K, Tantravahi R, Ritz J, Koeffler HP, Takeuchi S, Janssen JWG, Seriu T, Bartram CR, Sallan SE, Gilliland DG, Golub TR: TEL/AML-1 dimerizes and is associated with a favourable outcome in childhood acute lymphoblastic leukemia. Blood 88:4252, 1996
3. Shurtleff SA, Buijs A, Behm FG, Rubnitz JE, Raimondi SC, Hancock ML, Chan GCF, Pui CH, Grosveld G, Downing JR: TEL/ AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 9:1985, 1995
4. Raynaud S, Cavé H, Baens M, Bastard C, Cacheux V, Grosgeorge J, Guidal-Giroux C, Guo C, Vilmer E, Marynen P, Grandchamp B: The 12;21 translocation involving TEL and deletion of the other TEL allele: Two frequently associated alterations found in childhood acute lymphoblastic leukemia. Blood 87:2891, 1996
5. Cayuela JM, Baruchel A, Orange C, Madani A, Auclerc MF, Daniel MT, Schaison G, Sigaux F: TEL/AML1 fusion RNA as a new target to detect minimal residual disease in pediatric B-cell precursor acute lymphoblastic leukemia. Blood 88:302, 1996
6. Liang DC, Chou TB, Chen JS, Shurtleff SA, Rubnitz JE, Downing JR, Pui CH, Shih LY: High incidence of TEL/AML1 fusion resulting from a cryptic t(12;21) in childhood B-lineage acute lymphoblastic leukemia in Taiwan. Leukemia 10:991, 1996
7. Kobayashi H, Satake N, Maseki N, Sakashita A, Kaneko Y: The der(21)t(12;21) chromosome is always formed in a 12;21 translocation associated with childhood acute lymphoblastic leukaemia. Br J Haematol 94:105, 1996
8. Nakao M, Yokota S, Horiike S, Taniwaki M, Kashima K, Sonoda Y, Koizumi S, Takaue Y, Matsushita T, Fujimoto T, Misawa S: Detection and quantification of TEL/AML1 fusion transcripts by polymerase chain reaction in childhood acute lymphoblastic leukemia. Leukemia 10:1463, 1996
9. Fears S, Vignon C, Bohlander SK, Smith S, Rowley JD, Nucifora G: Correlation between the ETV6/CBFA2 (TEL/AML1) fusion gene and karyotypic abnormalities in children with B-cell precursor acute lymphoblastic leukemia. Genes Chromosomes Cancer 17:127, 1996
10. Borkhardt A, Cazzangia G, Ludwig W-D, Mangioni S, Burci L, Schrappe M, Valsecchi MG, Riehm H, Lampert F, Basso G, Masera G, Harbott J, Biondi A: Does the TEL/AML1 expression define a subgroup of good prognosis? The results of the German (BFM) and Italian (AIEOP) ALL study group. Blood 88:451a, 1996 (abstr, suppl 1)
11. Chambost H, Michel G, Thuret I, Toiron Y, Brunet C, Capodano AM, Sainty D, Maraninchi D, Gabert J: TEL/AML1 transcript in childhood acute lymphoblastic leukemia: A new candidate for minimal residual disease study rather than a new prognosis factor? Br J Haematol 93:55, 1996 (abstr)
12. Rubnitz JE, Shuster JJ, Land VJ, Link MP, Pullen DJ, Camitta BM, Pui C-H, Downing JR, Behm FG: Case-control study of children with acute lymphoblastic leukemia confirms the favorable impact of TEL gene rearrangements: A Pediatric Oncology Group Study. Blood 88:450a, 1996 (abstr, suppl 1)
13. Romana SP, Poirel H, Leconiat M, Flexor M-A, Mauchauffé M, Jonveaux P, Macintyre EA, Berger R, Bernard OA: High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood 86:4263, 1995
14. Raynaud S, Mauvieux L, Cayuela JM, Bastard C, Bilhou-Nabera C, Debuire B, Bories D, Boucheix C, Charrin C, Fière D, Gabert J: TEL/AML1 fusion gene is a rare event in adult acute lymphoblastic leukemia. Leukemia 10:1529, 1996
15. Shih LY, Chou TB, Liang DC, Tzeng YS, Rubnitz JE, Downing JR, Pui CH: Lack of TEL/AML1 fusion transcript resulting from a cryptic t(12;21) in adult B lineage acute lymphoblastic leukemia in Taiwan. Leukemia 10:1456, 1996
16. Chambost H, Michel G, Thuret I, Toiron Y, Brunet C, Capodano AM, Perrimond H, Gabert J: TEL/AML1 transcript may not be an independent prognostic factor in childhood acute lymphoblastic leukemia. Blood 88:72a, 1996 (abstr, suppl 1)
17. van der Does-van den Berg A, Bartram CR, Basso G, Benoit Y, Biondi A, Debatin K, Haas OA, Harbott J, Kamps WA, Köller U, Lampert F, Ludwig W-D, Niemeyer CM, van Wering ER: Minimal demands for the diagnosis, the classification and the evaluation of treatment results of childhood acute lymphoblastic leukemia (ALL) in the "BFM-Family" Co-operative Group. Med Pediatr Oncol 20:497, 1992
18. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
19. Sambrock J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989
20. Schlieben S, Borkhardt A, Reinisch I, Ritterbach J, Janssen JWG, Ratei R, Schrappe M, Repp R, Zimmermann M, Kabisch H, Janka-Schaub G, Bartram CR, Ludwig WD, Riehm H, Lampert F, Harbott J: Incidence and clinical outcome of children with BCR/ ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92. Leukemia 10:957, 1996
21. Mann HB, Whitney DR: On a rest of whether one of two random variables is stochastically larger than the other. Ann Math Stat 18:50, 1947
22. Lanza C, Volpe G, Basso G, Gottardi E, Barisone E, Perfetto F, Madon E, Saglio G: Reappearance of the TEL/AML1 transcript during molecular follow-up of t(12;21) ALL is predictive of clinical relapse. Blood 88:72a, 1996 (abstr, suppl 1)
23. Reiter A, Schrappe M, Ludwig W-D, Hiddemann W, Sauter S, Henze G, Zimmermann M, Lampert F, Havers W, Niethammer D, Odenwald E, Ritter J, Mann G, Welte K, Gadner H, Riehm H: Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 84:3122, 1994
24. Schrappe M, Reiter A, Sauter S, Ludwig W-D, Wörmann B, Harbott J, Bender-Götze C, Dörffel W, Dopfer R, Frey E, Havers W, Henze G, Kühl J, Richter R, Ritter J, Treuner J, Zintl F, Odenwald E, Welte K, Riehm H: Conception and interim analysis of trial ALL-BFM 90 for the treatment of children and adolescents with acute lymphoblastic leukemia: Significance of therapy response in peripheral blood and bone marrow. Klin Padiatr 206:208, 1994
25. Janka-Schaub G, Harms D, Goebel U, Graubner U, Gutjahr P, Haas RJ, Jürgens H, Spaar HJ, Winkler K: Randomized comparison of rotational chemotherapy in high-risk acute lymphoblastic leukemia of childhood - Follow-up after 9 years. Eur J Pediatr 155:640, 1996
26. Niemeyer CM, Reiter A, Riehm H, Donnelly M, Gelber RD, Sallan SE: Comparative results of two intensive treatment programs for childhood lymphoblastic leukemia: The Berlin-Frankfurt-Münster and Dana-Farber Cancer Institute protocols. Ann Oncol 2:745, 1991
27. Schorin MA, Blattner S, Gelber RD, Tarbell NJ, Donnelly M, Dalton V, Cohen HJ, Sallan SE: Treatment of childhood acute lymphoblastic leukemia: Results of Dana-Farber Cancer Institute/ Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01. J Clin Oncol 12:740, 1994
28. Ueberall MA, Wenzel D, Hertzberg H, Langer T, Meier W, Berger-Jones K, Huk WJ, Neuhäuser G, Lampert F, Beck JD, Korinthenberg R, for the German Late Effects Working Group: CNS late effects after therapy in childhood. II. Conventional EEG recordings in asymptomatic long-term survivors of childhood ALL - An evaluation of the interferences between neurophysiology, neurology, psychology, and CNS morphology. Med Pediatr Oncol 29:121, 1997
29. Brouwers P, Poplack D: Memory and learning sequelae in long-term survivors of acute lymphoblastic leukemia: Association with attention deficits. Am J Pediatr Hematol Oncol 12:174, 1990
30. Chessells JM, Cox TC, Kendall B, Cavanagh NP, Jannoun L, Richards S: Neurotoxicity in lymphoblastic leukaemia: Comparison of oral and intramuscular methotrexate and two doses of radiation. Arch Dis Child 65:416, 1990
31. Ochs J, Mulhern R: Long-term sequelae of therapy for childhood acute lymphoblastic leukaemia. Baillieres Clin Haematol 7:365, 1994
32. Ochs J, Mulhern R, Fairclough D, Parvey L, Whitaker J, Ch'ien L, Mauer A, Simone J: Comparison of neuropsychologic functioning and clinical indicators of neurotoxicity in long-term survivors of childhood leukemia given cranial radiation or parenteral methotrexate: A prospective study. J Clin Oncol 9:145, 1991